"Onslow Memorial Hospital is a 162-bed facility located in coastal North Carolina. Our medical staff of over 100 doctors is credentialed in over 25 specialty areas. The hospital offers state-of-the-art diagnostic services, including a Women's Imaging Center, Heartburn Center, Cardiac Cath Lab, Neurodiagnostic Lab, MRI, and CT Scan. Onslow Memorial also has a modern Labor and Delivery suite with a state-of-the-art monitoring system, NICU, Newborn Nursery, Intensive Care Unit/Coronary Care Unit, Medical and Surgical Services, and Rehabilitation Services. Our Emergency Department and Minor Emergency Care Unit treat more than 50,000 patients annually. We provide excellent patient health services in a healing and family-centered environment."

During the past decade, Onslow Memorial Hospital conducted 70 clinical trials. In the 10-year time frame, 70 clinical trials started and 36 clinical trials were completed, i.e. on average, 51.4% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 34 clinical trials were completed. i.e. 1133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Onslow Memorial Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 38 trials, followed by "SWOG Cancer Research Network" with 19 trials sponsored, "Alliance for Clinical Trials in Oncology" with 10 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 8 trials sponsored and "Wake Forest University Health Sciences" with 8 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Onslow Memorial Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 42 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "NRG Oncology" with 6 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Division of Cancer Control" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Onslow Memorial Hospital" are "Recurrent Squamous Cell Lung Carcinoma" (7 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (6 trials), "Recurrent Breast Carcinoma" (5 trials), "Stage IIIA Breast Cancer" (4 trials) and "Stage IV Cutaneous Melanoma AJCC v6 and v7" (4 trials). Many other conditions were trialed in "Onslow Memorial Hospital" in a lesser frequency.

Most popular intervention types in "Onslow Memorial Hospital" are "Drug" (63 trials), "Other" (59 trials), "Biological" (32 trials), "Procedure" (20 trials) and "Radiation" (4 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (35 trials), "Quality-of-Life Assessment" (20 trials), "Nivolumab" (14 trials), "Computed Tomography" (12 trials) and "Biospecimen Collection" (10 trials). Other intervention names were less common.

The vast majority of trials in "Onslow Memorial Hospital" are 71 trials for "All" genders, 12 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Onslow Memorial Hospital". undefined are not yet recruiting, 13 are recruiting, 51 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Onslow Memorial Hospital, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Onslow Memorial Hospital, 3 "Phase 1" clinical trials were conducted, 46 "Phase 2" clinical trials and 40 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".